Sarmazenil
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
Ethyl 7-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 78771-13-8 |
ATCvet code | QV03AB91 (WHO) |
PubChem | CID: 71231 |
ChemSpider | 64366 |
UNII | F84AE7X24P |
ChEMBL | CHEMBL46547 |
Chemical data | |
Formula | C15H14ClN3O3 |
Molecular mass | 319.743 g/mol |
|
|
|
|
(what is this?) (verify) |
Sarmazenil (Ro15-3505) is a drug from the benzodiazepine family. It acts as a partial inverse agonist of benzodiazepine receptors,[1] meaning that it causes the opposite effects to most benzodiazepine drugs, and instead acts as an anxiogenic and convulsant. It is used in veterinary medicine to reverse the effects of benzodiazepine sedative drugs in order to rapidly re-awaken anesthetized animals.[2][3][4]
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Anxiogenics
- Carboxylate esters
- Chloroarenes
- Convulsants
- Ethyl esters
- GABAA receptor negative allosteric modulators
- Imidazobenzodiazepines
- Lactams
- Nervous system drug stubs